Market Overview

Cramer Gives His Opinion On BioXcel, Schrodinger And More

Cramer Gives His Opinion On BioXcel, Schrodinger And More

On CNBC's "Mad Money Lightning Round," Jim Cramer said that BioXcel Therapeutics Inc (NASDAQ: BTAI) has all the great buzz words. It's biopharma and artificial intelligence. Cramer is willing to bless it as a spec.

Schrodinger Inc (NASDAQ: SDGR) is just not a great company, said Cramer. He doesn't like the stock.

Instead of Dada Nexus Ltd - ADR (NASDAQ: DADA), Cramer would buy Alibaba Group Holding Ltd - ADR (NYSE: BABA).

Cramer is not a buyer of HCA Healthcare Inc (NYSE: HCA). He explained that people think that estimates are too high and the stock will probably trade lower. He added that it is very expensive to run a hospital right now and there has been a lot of turmoil because of the pandemic.

Cramer doesn't want to own ADT Inc (NYSE: ADT). He doesn't like it and he thinks it is not run very well.

Five9, Inc. (NASDAQ: FIVN) is the best contact call center and Cramer can't believe that it hasn't been taken over by someone.


Related Articles (BABA + ADT)

View Comments and Join the Discussion!

Posted-In: CNBC Jim Cramer mad money Lightning RoundMedia